Preclinical News and Research

RSS
New method of delivery of gene therapy may lead to safer treatment for cancer

New method of delivery of gene therapy may lead to safer treatment for cancer

Research breakthrough in treatment of TB and MDR-TB

Research breakthrough in treatment of TB and MDR-TB

Myriad Genetics initiates phase 3 clinical trial of Flurizan

Myriad Genetics initiates phase 3 clinical trial of Flurizan

Escalating demand for novel and effective therapeutic approaches underlines growing appeal of peptides

Escalating demand for novel and effective therapeutic approaches underlines growing appeal of peptides

Recent study correlates human cord blood cells with reduced animal heart attack damage

Recent study correlates human cord blood cells with reduced animal heart attack damage

Potential new therapies for cancer and bleeding disorders

Potential new therapies for cancer and bleeding disorders

First program to apply RNA interference (RNAi) technology to asthma

First program to apply RNA interference (RNAi) technology to asthma

Stem cells from umbilical cord blood effectively treated heart attacks

Stem cells from umbilical cord blood effectively treated heart attacks

Paclitaxel may benefit Alzheimer's and Parkinson's movement disorders

Paclitaxel may benefit Alzheimer's and Parkinson's movement disorders

Cancer drug paclitaxel may reduce the adverse effects of Alzheimer's disease

Cancer drug paclitaxel may reduce the adverse effects of Alzheimer's disease

European market for bone morphogenic proteins in spine fusion

European market for bone morphogenic proteins in spine fusion

Pharmaceutical, biotechnology and drug discovery companies are increasingly turning their attention to cell-based assays

Pharmaceutical, biotechnology and drug discovery companies are increasingly turning their attention to cell-based assays

Escalating costs and lengthy clinical trials are major concerns for researchers in the field of drug discovery

Escalating costs and lengthy clinical trials are major concerns for researchers in the field of drug discovery

Alliance to develop and commercialize fully-human anti-anthrax antibody

Alliance to develop and commercialize fully-human anti-anthrax antibody

Positive results from phase 2 trial of Telintra, drug candidate in myelodysplastic syndrome

Positive results from phase 2 trial of Telintra, drug candidate in myelodysplastic syndrome

Bcl-6 oncogene - genetic target for lymphoma treatment

Bcl-6 oncogene - genetic target for lymphoma treatment

Novel anti-obesity compound shows promise for treatment of obesity

Novel anti-obesity compound shows promise for treatment of obesity

MedImmune and Medarex have announced a collaboration to develop antibodies

MedImmune and Medarex have announced a collaboration to develop antibodies

Breakthrough HIV research wins prestigious industry award

Breakthrough HIV research wins prestigious industry award

Brain imaging shows differences in people at risk for Alzheimer's

Brain imaging shows differences in people at risk for Alzheimer's